Medically reviewed by Drugs.com. Last updated on Dec 15, 2021.
Generic name: naldemedine tosylate 0.2mg
Dosage form: tablet
- Alteration of analgesic dosing regimen prior to initiating SYMPROIC is not required.
- Patients receiving opioids for less than 4 weeks may be less responsive to SYMPROIC [see Clinical Studies (14)].
- Discontinue SYMPROIC if treatment with the opioid pain medication is also discontinued.
Frequently asked questions
More about Symproic (naldemedine)
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 21 Reviews
- Drug class: peripheral opioid receptor antagonists
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.